With the CTD structure undergoing its largest update in 20 years, Diapharm examines the impact on future pharmaceutical submissions — and why it matters for industry leaders.

The EU Urban Waste Water Directive (UWWTD) is sparking significant debate across the pharmaceutical industry.

The European Medicines Agency (EMA) recently published updated Q&As that emphasize one thing above all: the importance of impartiality in third-party audits. Specifically, so-called “shared audits” — where a single audit report is sold to multiple companies — are now under increased regulatory scrutiny.